These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 35359389)

  • 1. Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship.
    Slominski RM; Sarna T; Płonka PM; Raman C; Brożyna AA; Slominski AT
    Front Oncol; 2022; 12():842496. PubMed ID: 35359389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities.
    Logesh R; Prasad SR; Chipurupalli S; Robinson N; Mohankumar SK
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188968. PubMed ID: 37657683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current update and trends in melanin pigmentation and melanin biology.
    Jimbow K
    Keio J Med; 1995 Mar; 44(1):9-18. PubMed ID: 7760535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma metastasis: What role does melanin play? (Review).
    Saud A; Sagineedu SR; Ng HS; Stanslas J; Lim JCW
    Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways.
    Slominski A; Kim TK; Brożyna AA; Janjetovic Z; Brooks DL; Schwab LP; Skobowiat C; Jóźwicki W; Seagroves TN
    Arch Biochem Biophys; 2014 Dec; 563():79-93. PubMed ID: 24997364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From tyrosine to melanin: Signaling pathways and factors regulating melanogenesis.
    Rzepka Z; Buszman E; Beberok A; Wrześniok D
    Postepy Hig Med Dosw (Online); 2016 Jun; 70(0):695-708. PubMed ID: 27356601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma.
    Hida T; Kamiya T; Kawakami A; Ogino J; Sohma H; Uhara H; Jimbow K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis.
    Slominski A; Paus R; Mihm MC
    Anticancer Res; 1998; 18(5B):3709-15. PubMed ID: 9854482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IFPCS presidential lecture: a chemist's view of melanogenesis.
    Ito S;
    Pigment Cell Res; 2003 Jun; 16(3):230-6. PubMed ID: 12753395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous photobiology. The melanocyte vs. the sun: who will win the final round?
    Kadekaro AL; Kavanagh RJ; Wakamatsu K; Ito S; Pipitone MA; Abdel-Malek ZA
    Pigment Cell Res; 2003 Oct; 16(5):434-47. PubMed ID: 12950718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of melanogenesis intermediates.
    Pavel S
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):162S-165S. PubMed ID: 8433003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Melanogenesis by Some Well-Known Polyphenolics: A Review.
    Orhan IE; Deniz FSS
    Curr Pharm Biotechnol; 2021; 22(11):1412-1423. PubMed ID: 33308130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical analysis of melanins and its application to the study of the regulation of melanogenesis.
    Ito S; Wakamatsu K; Ozeki H
    Pigment Cell Res; 2000; 13 Suppl 8():103-9. PubMed ID: 11041366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5,6-Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation.
    Del Bino S; Ito S; Sok J; Wakamatsu K
    Pigment Cell Melanoma Res; 2022 Nov; 35(6):622-626. PubMed ID: 35933709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating skin colour: role of the thioredoxin and glutathione systems in regulating melanogenesis.
    Lu Y; Tonissen KF; Di Trapani G
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33871027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells.
    Ancans J; Tobin DJ; Hoogduijn MJ; Smit NP; Wakamatsu K; Thody AJ
    Exp Cell Res; 2001 Aug; 268(1):26-35. PubMed ID: 11461115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of melanin monomers, dihydroxyindole-2-carboxylic acid (DHICA) and dihydroxyindole (DHI) on mammalian tyrosinase, with a special reference to the role of DHICA/DHI ratio in melanogenesis.
    Wilczek A; Mishima Y
    Pigment Cell Res; 1995 Apr; 8(2):105-12. PubMed ID: 7659677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the final phase of mammalian melanogenesis. The role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole.
    Aroca P; Solano F; Salinas C; García-Borrón JC; Lozano JA
    Eur J Biochem; 1992 Aug; 208(1):155-63. PubMed ID: 1511683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.
    Slominski A; Zbytek B; Slominski R
    Int J Cancer; 2009 Mar; 124(6):1470-7. PubMed ID: 19085934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin does not switch melanin synthesis towards pheomelanin in B16F10 cells.
    Wolnicka-Glubisz A; Nogal K; Żądło A; Płonka PM
    Arch Dermatol Res; 2015 Jan; 307(1):89-98. PubMed ID: 25398276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.